Literature DB >> 11242450

Milk immunoglobulins and complement factors.

H Korhonen1, P Marnila, H S Gill.   

Abstract

The importance of colostrum for the growth and health of newborn offspring is well known. In bovine colostrum, the antibody (immunoglobulin) complement system provides a major antimicrobial effect against a wide range of microbes and confers passive immunity until the calf's own immune system has matured. Bovine serum and lacteal secretions contain three major classes of immunoglobulins: IgG, IgM and IgA. The immunoglobulins are selectively transported from the serum into the mammary gland, as a result of which the first colostrum contains very high concentrations of immunoglobulins (40-200 mg/ml). IgG1 accounts for over 75 % of the immunoglobulins in colostral whey, followed by IgM, IgA and IgG2. All these immunoglobulins decrease within a few days to a total immunoglobulin concentration of 0.7-1.0 mg/ml, with IgG1 representing the major Ig class in milk throughout the lactation period. Together with the antibodies absorbed from colostrum after birth, the complement system plays a crucial role in the passive immunisation of the newborn calf. The occurrence of haemolytic or bactericidal complement activity in bovine colostrum and milk has been demonstrated in several studies. This review deals with the characteristics of bovine Igs and the complement system to be exploited as potential ingredients for health-promoting functional foods.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11242450     DOI: 10.1017/s0007114500002282

Source DB:  PubMed          Journal:  Br J Nutr        ISSN: 0007-1145            Impact factor:   3.718


  41 in total

Review 1.  Mammary gland immunity and mastitis susceptibility.

Authors:  Lorraine M Sordillo; Katie L Streicher
Journal:  J Mammary Gland Biol Neoplasia       Date:  2002-04       Impact factor: 2.673

2.  Pedimune in recurrent respiratory infection and diarrhoea--the Indian experience--the pride study.

Authors:  Kamlesh Patel; Rajiv Rana
Journal:  Indian J Pediatr       Date:  2006-07       Impact factor: 1.967

3.  Amoebicidal activity of milk, apo-lactoferrin, sIgA and lysozyme.

Authors:  Nidia León-Sicairos; Fernando López-Soto; Magda Reyes-López; Delfino Godínez-Vargas; Cynthia Ordaz-Pichardo; Mireya de la Garza
Journal:  Clin Med Res       Date:  2006-06

4.  Humoral immunity to AAV-6, 8, and 9 in normal and dystrophic dogs.

Authors:  Jin-Hong Shin; Yongping Yue; Bruce Smith; Dongsheng Duan
Journal:  Hum Gene Ther       Date:  2012-01-11       Impact factor: 5.695

5.  Oral administration of immunoglobulin G-enhanced colostrum alleviates insulin resistance and liver injury and is associated with alterations in natural killer T cells.

Authors:  T Adar; A Ben Ya'acov; G Lalazar; Y Lichtenstein; D Nahman; M Mizrahi; V Wong; B Muller; G Rawlin; Y Ilan
Journal:  Clin Exp Immunol       Date:  2012-02       Impact factor: 4.330

6.  Bovine colostrum contains immunoglobulin G antibodies against intimin, EspA, and EspB and inhibits hemolytic activity mediated by the type three secretion system of attaching and effacing Escherichia coli.

Authors:  Daniel A Vilte; Mariano Larzábal; Angel A Cataldi; Elsa C Mercado
Journal:  Clin Vaccine Immunol       Date:  2008-06-18

Review 7.  Bovine colostrum supplementation and exercise performance: potential mechanisms.

Authors:  Cecilia M Shing; Denise C Hunter; Lesley M Stevenson
Journal:  Sports Med       Date:  2009       Impact factor: 11.136

8.  Evolution of the mammary gland defense system and the ontogeny of the immune system.

Authors:  Armond S Goldman
Journal:  J Mammary Gland Biol Neoplasia       Date:  2002-07       Impact factor: 2.673

Review 9.  Growth hormone and prolactin--molecular and functional evolution.

Authors:  Isabel A Forsyth; Michael Wallis
Journal:  J Mammary Gland Biol Neoplasia       Date:  2002-07       Impact factor: 2.673

10.  Glycome characterization of immunoglobulin G from buffalo (Bubalus bubalis) colostrum.

Authors:  L S Mamatha Bhanu; M Amano; S-I Nishimura; H S Aparna
Journal:  Glycoconj J       Date:  2015-08-04       Impact factor: 2.916

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.